Cargando…

Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors

Structured treatment interruption (STI) has been trialed as an alternative to lifelong antiretroviral therapy (ART). We retrospectively performed single genome sequencing of the HIV-1 pol region from three patients representing different scenarios. They were either failing on continuous therapy (CT-...

Descripción completa

Detalles Bibliográficos
Autores principales: Kayondo, Jonathan K., Ndembi, Nicaise, Parry, Chris M., Cane, Patricia A., Hué, Stephane, Goodall, Ruth, Dunn, David T., Kaleebu, Pontiano, Pillay, Deenan, Mbisa, Jean L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505773/
https://www.ncbi.nlm.nih.gov/pubmed/25953118
http://dx.doi.org/10.1089/aid.2015.0035
_version_ 1782381588080754688
author Kayondo, Jonathan K.
Ndembi, Nicaise
Parry, Chris M.
Cane, Patricia A.
Hué, Stephane
Goodall, Ruth
Dunn, David T.
Kaleebu, Pontiano
Pillay, Deenan
Mbisa, Jean L.
author_facet Kayondo, Jonathan K.
Ndembi, Nicaise
Parry, Chris M.
Cane, Patricia A.
Hué, Stephane
Goodall, Ruth
Dunn, David T.
Kaleebu, Pontiano
Pillay, Deenan
Mbisa, Jean L.
author_sort Kayondo, Jonathan K.
collection PubMed
description Structured treatment interruption (STI) has been trialed as an alternative to lifelong antiretroviral therapy (ART). We retrospectively performed single genome sequencing of the HIV-1 pol region from three patients representing different scenarios. They were either failing on continuous therapy (CT-F), failing STI (STI-F), or suppressing on STI (STI-S). Over 460 genomes were generated from three to five different time points over a 2-year period. We found multiple-linked-resistant mutations in both treatment failures. However, the CT-F patient showed a stepwise accumulation of diverse, linked mutations whereas the STI-F patient had lineage turnover between treatment periods with recirculation of wild-type and resistant variants from reservoirs. The STI-F patient showed a 7-fold increase in the third codon position substitution rate relative to the first and second positions compared to a 2-fold increase for CT-F and increased purifying selection in the pol gene (62 vs. 22 sites, respectively). An understanding of intrapatient viral dynamics could guide the future direction of treatment interruption strategies.
format Online
Article
Text
id pubmed-4505773
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Mary Ann Liebert, Inc.
record_format MEDLINE/PubMed
spelling pubmed-45057732015-09-23 Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors Kayondo, Jonathan K. Ndembi, Nicaise Parry, Chris M. Cane, Patricia A. Hué, Stephane Goodall, Ruth Dunn, David T. Kaleebu, Pontiano Pillay, Deenan Mbisa, Jean L. AIDS Res Hum Retroviruses Sequence Notes Structured treatment interruption (STI) has been trialed as an alternative to lifelong antiretroviral therapy (ART). We retrospectively performed single genome sequencing of the HIV-1 pol region from three patients representing different scenarios. They were either failing on continuous therapy (CT-F), failing STI (STI-F), or suppressing on STI (STI-S). Over 460 genomes were generated from three to five different time points over a 2-year period. We found multiple-linked-resistant mutations in both treatment failures. However, the CT-F patient showed a stepwise accumulation of diverse, linked mutations whereas the STI-F patient had lineage turnover between treatment periods with recirculation of wild-type and resistant variants from reservoirs. The STI-F patient showed a 7-fold increase in the third codon position substitution rate relative to the first and second positions compared to a 2-fold increase for CT-F and increased purifying selection in the pol gene (62 vs. 22 sites, respectively). An understanding of intrapatient viral dynamics could guide the future direction of treatment interruption strategies. Mary Ann Liebert, Inc. 2015-07-01 /pmc/articles/PMC4505773/ /pubmed/25953118 http://dx.doi.org/10.1089/aid.2015.0035 Text en © Jonathan K. Kayondo, et al. 2015; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (<http://creativecommons.org/licenses/by/4.0>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Sequence Notes
Kayondo, Jonathan K.
Ndembi, Nicaise
Parry, Chris M.
Cane, Patricia A.
Hué, Stephane
Goodall, Ruth
Dunn, David T.
Kaleebu, Pontiano
Pillay, Deenan
Mbisa, Jean L.
Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors
title Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors
title_full Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors
title_fullStr Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors
title_full_unstemmed Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors
title_short Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors
title_sort intrapatient evolutionary dynamics of human immunodeficiency virus type 1 in individuals undergoing alternative treatment strategies with reverse transcriptase inhibitors
topic Sequence Notes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505773/
https://www.ncbi.nlm.nih.gov/pubmed/25953118
http://dx.doi.org/10.1089/aid.2015.0035
work_keys_str_mv AT kayondojonathank intrapatientevolutionarydynamicsofhumanimmunodeficiencyvirustype1inindividualsundergoingalternativetreatmentstrategieswithreversetranscriptaseinhibitors
AT ndembinicaise intrapatientevolutionarydynamicsofhumanimmunodeficiencyvirustype1inindividualsundergoingalternativetreatmentstrategieswithreversetranscriptaseinhibitors
AT parrychrism intrapatientevolutionarydynamicsofhumanimmunodeficiencyvirustype1inindividualsundergoingalternativetreatmentstrategieswithreversetranscriptaseinhibitors
AT canepatriciaa intrapatientevolutionarydynamicsofhumanimmunodeficiencyvirustype1inindividualsundergoingalternativetreatmentstrategieswithreversetranscriptaseinhibitors
AT huestephane intrapatientevolutionarydynamicsofhumanimmunodeficiencyvirustype1inindividualsundergoingalternativetreatmentstrategieswithreversetranscriptaseinhibitors
AT goodallruth intrapatientevolutionarydynamicsofhumanimmunodeficiencyvirustype1inindividualsundergoingalternativetreatmentstrategieswithreversetranscriptaseinhibitors
AT dunndavidt intrapatientevolutionarydynamicsofhumanimmunodeficiencyvirustype1inindividualsundergoingalternativetreatmentstrategieswithreversetranscriptaseinhibitors
AT kaleebupontiano intrapatientevolutionarydynamicsofhumanimmunodeficiencyvirustype1inindividualsundergoingalternativetreatmentstrategieswithreversetranscriptaseinhibitors
AT pillaydeenan intrapatientevolutionarydynamicsofhumanimmunodeficiencyvirustype1inindividualsundergoingalternativetreatmentstrategieswithreversetranscriptaseinhibitors
AT mbisajeanl intrapatientevolutionarydynamicsofhumanimmunodeficiencyvirustype1inindividualsundergoingalternativetreatmentstrategieswithreversetranscriptaseinhibitors